Sign in to continue:

Saturday, February 14th, 2026

LHN Limited Announces S$0.02 Dividend Payout: Key Dates for Shareholders in Singapore and Hong Kong






Double Dividend Delight: LHN Limited Announces Final and Special Dividends for 2024


Double Dividend Delight: LHN Limited Announces Final and Special Dividends for 2024

LHN Limited has announced a significant update that is likely to capture the attention of its shareholders and the market at large. The board of directors has recommended the payment of both a final dividend and a special dividend for the financial year ending 30 September 2024. This proposal, subject to shareholder approval at the annual general meeting (AGM) scheduled for 24 January 2025, presents an exciting potential for value addition to shareholders.

Key Dividend Details

  • The proposed final dividend is S\$0.01 (equivalent to HK\$0.0578) per ordinary share.
  • The proposed special dividend is also S\$0.01 (equivalent to HK\$0.0578) per share.
  • Upon approval, the final dividend will be distributed on 21 February 2025, and the special dividend on 30 May 2025.

Special Dividend Options and Scrip Dividend Scheme

Shareholders will have flexibility with the special dividend through the Scrip Dividend Scheme, which allows them to receive the dividend in the form of scrip shares, cash, or a combination of both. This scheme is contingent upon approval from the AGM and the respective stock exchanges’ permissions.

Important Dates for Shareholders

  • For Singapore shareholders, the register of members closes at 5:00 p.m. on 7 February 2025 for the final dividend and at 5:00 p.m. on 10 April 2025 for the special dividend.
  • For Hong Kong shareholders, the register closes between 10-11 February 2025 for the final dividend and between 11-14 April 2025 for the special dividend.

Potential Impact on Share Price

This announcement could influence LHN Limited’s share price positively, as dividend declarations often lead to investor optimism and increased buying interest.

The Board comprises Executive Chairman and Group Managing Director Lim Lung Tieng, Executive Director Lim Bee Choo, and Independent Non-Executive Directors Ch’ng Li-Ling, Yong Chee Hiong, and Chan Ka Leung Gary.

Disclaimer: This article is for informational purposes only and does not constitute financial advice. Please consult with a financial advisor before making any investment decisions.




View LHN Historical chart here



AJJ Medtech Appoints William Ong as CEO of AJJ Healthcare to Drive AI-Driven Innovation and Growth in Singapore’s Healthcare Sector 1

AJJ Medtech Appoints Healthcare Veteran William Ong as CEO of Subsidiary – Signals Strategic Expansion into AI, Robotics, and ESG AJJ Medtech Appoints Healthcare Veteran William Ong as CEO of Subsidiary – Signals Strategic...

UOBAM Ping An FTSE ASEAN Dividend Index ETF Granted Multiple SGX-ST Listing Rule Waivers – Key Details and Investor Implications

UOB Asset Management Receives SGX Waivers for Ping An FTSE ASEAN Dividend Index ETF UOB Asset Management Secures SGX Waivers for Ping An FTSE ASEAN Dividend Index ETF Date: 7 January 2025 Issuer: UOB...

BBR Holdings Announces Incorporation of 51%-Owned Subsidiary SECHK Pte Ltd in Singapore – SGX Rule 706A Update 1

BBR Holdings Expands with New Singapore Subsidiary: What Investors Need to Know BBR Holdings Expands with New Singapore Subsidiary: What Investors Need to Know Key Points from the Latest Announcement BBR Holdings (S) Ltd...